EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice - Aix-Marseille Université Access content directly
Journal Articles European Respiratory Journal Year : 2017

EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice

Marie Wislez

Domains

Cancer

Dates and versions

hal-01699297 , version 1 (02-02-2018)

Identifiers

Cite

Pascale Tomasini, Solenn Brosseau, Julien Mazières, Jean Merlio, Michèle Beau-Faller, et al.. EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice. European Respiratory Journal, 2017, 50 (2), pii: 1700514. ⟨10.1183/13993003.00514-2017⟩. ⟨hal-01699297⟩
207 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More